GAMES: GameSpot | GameFAQs MUSIC: Last.fm | MP3.com MOVIES: Metacritic | Movietome TV: TV.com
Home | About Metacritic | About Metascores | What's New | Wireless Versions | Discussion Forums | Advertising Inquiries | Contact Us | RSS
Metacritic.com: We Deal With Criticism
     Help
> Switch to Advanced Search  
Film Video/DVD Music Games TV

Books

All-Time High Scores
Best Of 2006
Best Of 2005
Best Of 2004
How Metascores Are Calculated
Discuss Books In Our Forums

 

Upcoming & Recent Releases

sort by name sort by score

 

Upcoming & Recent Releases

sort by name sort by score

Stars indicate the most critically-acclaimed books.

 

 



Printer-Friendly Version Email This Page Discuss In Our Forums

The Truth About The Drug Companies
How They Deceive Us And What To Do About It
by Marcia Angell

The Truth About The Drug Companies reviews
Critic Score
Metascore: 75 Metascore out of 100
User Score  
7.0 out of 10
based on 11 reviews
read critic reviews
how did we calculate this?
based on 1 vote
read user comments
rate this book

The former editor of the New England Journal Of Medicine offers a thorough attack against the pharmaceutical industry (not surprisingly, our nation's most profitable industry), encompassing criticism against not just drug giants such as Pfizer but also the government and even medical practitioners. She also offers suggestions for reforming the industry and reducing prescription drug prices for end users.

Random House, 336 pages
08/24/2004
$24.95

ISBN: 0375508465

Nonfiction
Current Events & Politics
Health & Medicine

What The Critics Said

All reviews are classified as one of five grades: Outstanding (4 points), Favorable (3), Mixed (2), Unfavorable (1) and Terrible (0). To calculate the Metascore, we divide total points achieved by the total points possible (i.e., 4 x the number of reviews), with the resulting percentage (multiplied by 100) being the Metascore. Learn more...

Library Journal
Every registered voter should read this book. [Jul 2004, p.110]
Publishers Weekly
The Fast Food Nation of the drug industry. [2 Aug 2004, p.63]
Boston Globe Carl Elliott
A lucid, persuasive, and highly important book.
Read Full Review
Chicago Sun-Times Jim Ritter
While her revelations aren't new, Angell does an excellent job assembling them into a convincing case against Big Pharma.
Read Full Review
The New York Times Janet Maslin
Dr. Angell's case is tough, persuasive and troubling.
Read Full Review
The New York Times Book Review Stephen S. Hall
Gives a vivid historical context.
Read Full Review
The Globe And Mail [Toronto] Alison Motluk
I wanted more of the story behind how things happened, more of the complexity and nuance. Still, even as a skeletal primer, this is an excellent and important book. [11 Sep 2004, p. D4]
Booklist David Siegfried
Angell provides a sensible, enlightened approach. [Aug 2004, p.1883]
Washington Post David Tuller
Most of what she covers here... has been reported before in both the mainstream press and professional publications. But she braids all the strands together and delivers the message... in a convincing, no-nonsense manner.
Read Full Review
The New Republic David J. Rothman
Angell ably takes us through the territory in clean and clear prose. But... its argument often lacks complexity. And most disappointing, Angell has very little to say about the best strategies for change.
Read Full Review
Wall Street Journal Henry I. Miller
Dr. Angell's tome is not enlightening. Her diagnoses are wrong, and her cures are far worse than the disease.
Read Full Review

What Our Users Said

Vote Now!The average user rating for this book is 7.0 (out of 10) based on 1 User Votes
Note: User votes are NOT included in the Metascore calculation.

Discuss this book in our forums

Return to top of page
Home | FILM | DVD/VIDEO | MUSIC | GAMES | TV | Forums | About Metacritic metacritic.com

Popular on CBS sites: MLB | Spore | iPhone 3G | Paris Hilton | Antivirus Software | GPS | Recipes | Shwayze | NFL

About CBS Interactive | Jobs | Advertise

© 2008 CBS Interactive Inc. All rights reserved. | Privacy Policy | Terms of Use